Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance
ISTANBUL escrs









Take a look inside the London 2014 Congress

video-icon

Then register to join us
in Barcelona!





Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Repeatability of measurements obtained with 3 topographers in keratoconic and normal corneas

Poster Details

First Author: E.Guilbert FRANCE

Co Author(s):    A. Saad   M. Elluard   A. Grise-Dulac   H. Rouger   D. Gatinel        

Abstract Details

Purpose:

To assess the repeatability of the corneal topograph function of Orbscan II, OPD-Scan III and iTrace in keratoconus and to compare it to the repeatability of measurements obtained in a control group of normal patients.

Setting:

Prospective cohort study. Patients were prospectively recruited from the Department of Refractive Surgery at the Rothschild Ophthalmic Foundation, Paris, France between November 2011 and May 2012.

Methods:

Three successive measurements were performed with each device. Main outcome measure : repeatability limit of keratometric readings.

Results:

Fifty-nine keratoconic eyes of 34 patients and 54 normal eyes of 27 subjects were included in this study. For all studied parameters, repeatability limit was higher, and thus the repeatability was lower, in keratoconic eyes compared to normal eyes, with the 3 topographers used. For maximum keratometry measurement, it was 1.73, 1.49 and 1.24 diopters in patients group and 0.61, 0.37 and 1.02 diopters in control group with Orbscan II, OPD-Scan III and iTrace, respectively. For minimum keratometry measurement, it was 1.45, 1.62 and 1.42 diopters in patients group and 0.65, 0.32 and 0.91 diopters in control group, respectively.

Conclusions:

Topographies performed in keratoconic eyes are less reliable than those performed in normal eyes. Values of the thresholds of keratometric changes used to acertain keratoconus progression might be reconsidered. Caution should be taken when interpreting the topographies of such patients, and their higher variability should be taken into account.

Financial Disclosure:

One or more of the authors receives non-monetary benefits from a company producing, developing or supplying the product or procedure presented., One or more of the authors travel has been funded, fully or partially, by a competing company, One or more of the authors travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented

Back to Poster listing